CN116790637A - Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof - Google Patents
Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof Download PDFInfo
- Publication number
- CN116790637A CN116790637A CN202310765301.2A CN202310765301A CN116790637A CN 116790637 A CN116790637 A CN 116790637A CN 202310765301 A CN202310765301 A CN 202310765301A CN 116790637 A CN116790637 A CN 116790637A
- Authority
- CN
- China
- Prior art keywords
- gene
- atrans
- anthocyanin
- akebia
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 80
- 229930002877 anthocyanin Natural products 0.000 title claims abstract description 65
- 235000010208 anthocyanin Nutrition 0.000 title claims abstract description 65
- 239000004410 anthocyanin Substances 0.000 title claims abstract description 65
- 150000004636 anthocyanins Chemical class 0.000 title claims abstract description 65
- 244000036770 Akebia trifoliata Species 0.000 title claims abstract description 32
- 235000012980 Akebia trifoliata Nutrition 0.000 title claims abstract description 32
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 29
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 15
- 108700005075 Regulator Genes Proteins 0.000 title claims abstract description 9
- 241000722953 Akebia Species 0.000 claims abstract description 41
- 239000013598 vector Substances 0.000 claims abstract description 30
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- 230000002018 overexpression Effects 0.000 claims abstract description 16
- 230000030279 gene silencing Effects 0.000 claims abstract description 14
- 239000002773 nucleotide Substances 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 8
- 238000010367 cloning Methods 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 9
- 230000028604 virus induced gene silencing Effects 0.000 claims description 7
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 5
- 238000012226 gene silencing method Methods 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 238000009395 breeding Methods 0.000 claims description 2
- 230000001488 breeding effect Effects 0.000 claims description 2
- 238000009825 accumulation Methods 0.000 abstract description 12
- 101150081540 ANS gene Proteins 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 description 26
- 238000002347 injection Methods 0.000 description 17
- 239000007924 injection Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 101710199202 Anthocyanin synthase Proteins 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 241000589158 Agrobacterium Species 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011529 RT qPCR Methods 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- 241000234282 Allium Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- 102000016680 Dioxygenases Human genes 0.000 description 3
- 108010028143 Dioxygenases Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000003766 bioinformatics method Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- 241001499808 Allium atrorubens Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229910002547 FeII Inorganic materials 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000522169 Lespedeza Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108091005763 multidomain proteins Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12019—2-Oxuglutarate dioxygenase (ethylene-forming) (1.13.12.19)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the technical field of akebia trifoliate planting and discloses an anthocyanin synthesis regulatory gene AtrANS of akebia trifoliate, and a coding protein and application thereof. The invention discovers the anthocyanin synthesis regulatory gene AtrANS of akebia trifoliate for the first time, and discloses the nucleotide sequence and the sequence of the coding protein thereof, and can promote the accumulation of anthocyanin by expressing an ANS gene in the akebia trifoliate transiently, and can reduce the accumulation of anthocyanin by silencing the gene. The invention also discloses an overexpression vector and a silencing vector containing the AtrANS gene, and provides application of the gene AtrANS in improving anthocyanin content in the pericarp of akebia trifoliata and in cultivating plant varieties with high anthocyanin content.
Description
Technical Field
The invention belongs to the technical field of akebia trifoliate planting, and particularly relates to an anthocyanin synthesis regulatory gene AtrANS of akebia trifoliate, and a coding protein and application thereof.
Background
Akebia trifoliata (Akebia trifoliate) (thunder) Koidz.) belongs to Akebia of Akebiaceae, is used as a wild vine fruit tree, is widely distributed in more than 20 provinces and cities in China, is used for medicine, food, oil and appreciation, is rich in nutrition, wide in seed adaptation area, large in yield increase potential and high in economic benefit. The pericarp of akebia trifoliate is various in color, green in immature state, and the color is changed greatly in mature state, and the pericarp is changed into white, pink, purple and other colors. The Akebia trifoliata has important edible and ornamental values, the Akebia trifoliata is taken as a novel fruit, the appearance quality such as the color of the fruit peel, the shape and the size of the fruit and the like of the Akebia trifoliata directly influences the commodity value of the Akebia trifoliata, the color of the fruit peel is taken as an important agronomic property of the Akebia trifoliata, good color, flavor and quality can be shown only after the fruit is ripe to a certain extent, the appearance color of the fruit is the most visual expression of whether each property of the fruit meets the purchase requirements of people and is ripe, and the significance is great. As an ornamental plant, fruit viewing is also an important content, color is one of the most important ornamental traits of ornamental plants, and pigment metabolism has been a research hotspot in ornamental plants.
Anthocyanin is an important flavonoid compound, comes from the phenylpropionic acid/flavonoid biosynthesis pathway, is a glycosylated polyphenol compound, belongs to a large class of plant secondary metabolites, and has a series of colors from blue to red to purple in flowers, seeds, fruits and nutrient tissues. In akebia trifoliate, the fruit quality of the akebia trifoliate is affected by the main pigment substance determining the color of the pericarp, and the colored fruits are hardly accepted by consumers in the market. The anthocyanin is taken as a plant pigment with natural biological activity, has strong oxidation resistance, is vital to plant adaptation and severe environmental condition resistance due to synthesis and accumulation in a nutrition organ, and can enhance the resistance of plants to different biotic and abiotic stresses. Furthermore, foods rich in anthocyanins are becoming increasingly popular for their attractive color and benefit to human health. Such as preventing cardiovascular diseases, reducing diabetes, controlling obesity, etc.
ANS (anthocyanin synthase) is the 2 nd key enzyme in the middle and later stages of anthocyanin synthesis, is a dioxygenase dependent on FeII/2-oxoglutarate, can catalyze the dehydroxylation of C-4, forms a double bond on the C ring, converts colorless anthocyanin into colored anthocyanin, and is of great importance to the color formation of plants. Some reports reveal that ANS is involved in regulating anthocyanin biosynthesis, and that point mutations occur in the ANS gene in onion scales, which alter the color of guarana and american red onion scales; the recombinant PpANS protein in peach can catalyze the formation of anthocyanin from colorless anthocyanin; the pink property of onion is related to mutation of ANS gene, and the expression quantity is obviously reduced in pink onion; whereas ANS overexpression increases the accumulation of flavonoids and anthocyanins in rice (Oryza sativa L) plants, the seed coats appear purplish red. These results demonstrate that the ANS gene can be involved in plant anthocyanin biosynthesis. At present, the effect of an ANS gene in the synthesis of the anthocyanin of akebia trifoliate is not reported yet.
Currently, the research on the biosynthesis regulation of the anthocyanin of the akebia trifoliate is limited, so that candidate genes for the biosynthesis regulation of the anthocyanin of the akebia trifoliate are excavated, and theoretical and technical support can be provided for quality improvement and molecular breeding of the akebia trifoliate or other genus of the akebia trifoliate.
Disclosure of Invention
The invention aims to solve the technical problems and overcome the defects and shortcomings in the background technology, and provides an Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS, and a coding protein and application thereof.
In order to solve the technical problems, the technical scheme provided by the invention is as follows:
the nucleotide sequence of the Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS is shown as SEQ ID NO: 1.
A primer pair for cloning the gene AtrANS according to claim 1, wherein the base sequence is as follows:
an upstream primer: 5'-AATTGCACCAAGACGAAA-3' (SEQ ID NO: 3);
a downstream primer: 5'-AATGTCATCAAGAGTGGTAC-3' (SEQ ID NO: 4).
An over-expression vector comprising the vector PBI121-GFP, comprising the gene AtrANS according to claim 1 in said vector PBI 121.
A primer pair for constructing the overexpression vector according to claim 3, which has the following base sequence:
an upstream primer: 5'-GAGAACACGGGGGACTCTAGAATGGCAACACAAGTAGAGTAAAGTT ACA-3' (SEQ ID NO: 5);
a downstream primer: 5'-GCTCACCATGGATCCTCTAGATTATTTGGAGAGGAGAGTTTCTTGG-3' (SEQ ID NO: 6).
A virus-induced gene silencing vector comprising vector TRV2, comprising the gene atrabs of claim 1 in the vector TRV 2.
A primer pair for constructing the gene silencing vector of claim 5, having the following base sequence:
an upstream primer: 5'-AAGGTTACCGAATTCTCTAGAACTAAAGGCTGTTGGTGAAGCTTT-3' (SEQ ID NO: 7);
a downstream primer: 5'-TCCCCATGGAGGCCTTCTAGAATCTCTATGGTGTCCCCAATGTG-3' (SEQ ID NO: 8).
The coding protein of the gene AtrANS has an amino acid sequence shown in SEQ ID NO: 2.
Based on a general inventive concept, the invention also provides application of the gene AtrANS in improving anthocyanin content in akebia trifoliate peel.
Based on a general inventive concept, the invention also provides application of the gene AtrANS in cultivating new varieties of high anthocyanin plants.
Preferably, the plant is akebia trifoliata.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention discovers the anthocyanin synthesis regulatory gene AtrANS of akebia trifoliate for the first time, and discloses the nucleotide sequence and the sequence of the coding protein thereof, and can promote the accumulation of anthocyanin by expressing an ANS gene in the akebia trifoliate transiently, and can reduce the accumulation of anthocyanin by silencing the gene.
2. The invention also discloses an overexpression vector and a silencing vector containing the AtrANS gene, and provides application of the gene AtrANS in improving anthocyanin content in the pericarp of akebia trifoliata and in cultivating plant varieties with high anthocyanin content.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, and it is obvious that the drawings in the following description are some embodiments of the present invention, and other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 is an analysis of the functional domain of the amino acid sequence of the AtrANS in an embodiment of the invention;
FIG. 2 is an analysis of the expression of the AtrANS gene in different phenotypes of Akebia trifoliata (note: white peel (LW), pink peel (GP), purple peel (ZP); S1, green ripening stage; S2, color shifting stage; S3, coloring stage);
FIG. 3 is a graph showing that overexpression of AtrANS in the pericarp of Akebia trifoliata promotes anthocyanin accumulation in the examples of the present invention; (A) The transient over-expression of the AtrANS gene is carried out on pericarps of akebia trifoliate, and the pericarps which are not injected are used as negative controls; (B) One week after injection, the real-time expression level of the atrabs around the injection site; (C) anthocyanin content in the pericarp around the injection site; data are mean of 3 independent biological replicates, statistically analyzed against corresponding controls using Student's t test (< 0.05, <0.01, < P);
FIG. 4 is a functional analysis of the AtrANS gene based on TRV virus-induced gene silencing in an embodiment of the invention; (a) silencing of the atrANS gene during the transchronicity of Akebia trifoliata; (C) One week after injection, the relative expression of atrabs around the injection site; (B) pericarp anthocyanin content around injection site; data are mean of 3 independent biological replicates, statistically analyzed with the Student's t test against the corresponding control (P <0.05, < P < 0.01).
Detailed Description
The present invention will be described more fully hereinafter with reference to the accompanying drawings, in which preferred embodiments are shown, for the purpose of illustrating the invention, but the scope of the invention is not limited to the specific embodiments shown.
Unless defined otherwise, all technical and scientific terms used hereinafter have the same meaning as commonly understood by one of ordinary skill in the art. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the scope of the present invention.
Unless otherwise specifically indicated, the various raw materials, reagents, instruments, equipment and the like used in the present invention are commercially available or may be prepared by existing methods.
Examples:
the invention identifies the structural gene differentially expressed in the synthesis process of the pericarp anthocyanin of the akebia trifoliate and identifies a key ANS gene. The invention selects purple peel ZP (germplasm name is hybridization 30) as a template to separate and identify ANS genes in akebia trifoliate. The functional domain, the amino acid sequence, the three-dimensional structure of the protein, the isoelectric point and the like of the target gene in the akebia trifoliata obtained by cloning are analyzed through bioinformatics software, the biological function of the gene is predicted by combining related researches, and the gene is named as AtrANS based on the function prediction of the gene. Then, the function of the gene is verified by constructing an over-expression vector and constructing a TRV virus-mediated gene silencing expression vector to transiently transform the pericarp of akebia trifoliate. Analysis of phenotype and anthocyanin-like content of the treated fruits shows that the AtrANS gene plays a role in the biosynthesis of the anthocyanin of akebia trifoliate, and the experimental result provides a theoretical basis for the research on the regulation mechanism of the biosynthesis of the anthocyanin of akebia.
1. Test materials: akebia trifoliata fruits are collected from Akebia trifoliata resource nursery of the China institute of agricultural sciences of Yuan river, hunan province, and Akebia trifoliata fresh fruits are used for the instantaneous expression of the fruits.
2. The test method comprises the following steps:
2.1 extraction and reverse transcription of total RNA from pericarp of Akebia trifoliata
Total RNA for cloning the gene of interest was isolated from fresh pericarp samples of purple pericarp ZP using the SteadyPure plant RNA extraction kit (Ai Kerui Biotech Co., ltd., china Changsha) according to the kit instructions. The purity of the RNA samples was judged by agarose gel electrophoresis.
Using Thermo Scientific RevertAid First Strand cDNA Synthesis Kit reverse transcription kit, 10. Mu.L of total RNA extracted was used as template for reverse transcription, and the system and procedure are shown in Table 1.
TABLE 1 reverse transcription reaction system
2.2 cloning of the key gene AtrANS for anthocyanin synthesis from the pericarp of Akebia trifoliata
Based on sequence information of an atlans gene (Atr 08G 041820) in akebia trifoliate genome, wherein CDS length is 1279bp, primer design is carried out by using PrimerPremier5 software, and the primer is synthesized by Beijing qing biological science and technology Co., ltd, and the nucleotide sequence is as follows:
f end primer: AATTGCACCAAGACGAAA (SEQ ID NO: 3);
r terminal primer: AATGTCATCAAGAGTGGTAC (SEQ ID NO: 4);
the amplification of the target gene using ZP fruit cDNA as a template and KOD FX DNA Polymerase (TOYOBO, japan), PCR reaction system and PCR reaction procedure are shown in table 2.
TABLE 2PCR reaction System and program
First, the target gene PCR product was separated by 1.0% (W/V) agarose gel electrophoresis, and the presence or absence of a single bright target band was observed in a gel imaging system. Subsequently, the target band was recovered and purified using a gel recovery kit (Omega D2400-01, omega, U.S.A.). The purity of the product was determined by agarose gel electrophoresis.
2.3 cloning ligation and transformation of the Gene of interest AtrANS
The recovered gene product of interest was ligated into cloning vectors by blunt end ligation using the pEASY-Blunt Cloning Vector cloning vector kit (full gold Biotechnology Co., ltd., beijing) into Table 3. The ligation product was transformed into DH5a competence (Beijing, biotechnology Co., ltd.) by heat shock method, and after resuscitating, it was spread uniformly on LB medium containing kanamycin, and cultured in an incubator at 37℃overnight in an inverted manner to form single colonies. The monoclonal was picked up and scattered in 10. Mu.L of sterilized ultra pure water, and PCR was performed on the monoclonal with Taq DNA polymerase (full gold Biotechnology Co., beijing) using the universal primer on pEASY vector, and the reaction system and the procedure are shown in Table 4. Positive clone bacterial liquid is subjected to amplification culture in LB culture medium containing kanamycin, and then is entrusted to sequencing by Beijing qingke biotechnology Co. The sequencing result was aligned with the target gene CDS sequence by NCBI BlastN and DNAMAN Version 9.
TABLE 3 cloning vector ligation System and procedure
TABLE 4PCR reaction System and program
2.4 construction of the Gene expression vector of interest
Binary expression vector PBI121-GFP was used to construct expression vectors containing the ORF sequence of the AtrANS gene (Atr 08G 041820). The PBI121-GFP sequence is used as a carrier sequence, and the target gene sequence is used as a connecting sequence. Selecting Quick Cut TM XbaI is used as a restriction site, and a PCR primer with an enzyme cutting site is designed, wherein the nucleotide sequence is as follows:
f end primer: GAGAACACGGGGGACTCTAGAATGGCAACACAAGTAGAGTAAAGTTAC A (SEQ ID NO: 5);
r terminal primer: GCTCACCATGGATCCTCTAGATTATTTGGAGAGGAGAGTTTCTTGG (SEQ ID NO: 6);
PCR amplification (PCR amplification system as shown in Table 2) was performed using a cloning plasmid containing the ORF sequence of the AtrANS gene as a template, and the AtrANS gene fragment was obtained by agarose gel electrophoresis, gel recovery and purification. By QuickCut TM The PBI121-GFP plasmid DNA was digested with XbaI restriction enzyme, the reaction system is shown in Table 5, and the digested product was recovered and purified by electrophoresis to obtain a linearized vector fragment, and the purity and concentration were determined by agarose gel electrophoresis.
Using ClonExpress R II One Step Cloning Kit (Nanjinouzan Biotechnology Co., ltd., china) was subjected to seamless cloning ligation, and the AtrANS gene fragment was ligated with a linearized PBI121-GFP vector, the ligation system being shown in Table 6. The ligation product was transformed into DH5a competent cells (Peking Optimaceae)Science and technology Co., ltd., china) was uniformly spread on LB solid medium containing kanamycin, and cultured overnight at 37 ℃. The single clone growing on the plate is subjected to PCR detection by using an F end primer on the PBI121-GFP vector and an R end primer of the AtrANS gene, and then sequencing is carried out by the Beijing qing family biotechnology Co. The correctly sequenced monoclonal bacterial solution was selected for plasmid extraction, transformed with Agrobacterium GV3101 competent (Beijing engine biotechnology Co., ltd., china), then plated onto solid LB medium containing kanamycin and rifampicin, and cultured at 28℃for 2 days. After single colony growth, single clones were harvested for PCR validation, positive clones were grown up in liquid LB medium and stored in-80℃refrigerator with 1:1 of 50% glycerol for subsequent infection.
Table 5 cleavage reaction System and reaction procedure
Table 6 connection system
2.5 construction of silencing vector induced by the Gene VIGS Virus
Carrying out homologous comparison on CDS sequences of the AtrANS genes cloned from ZP Akebia trifoliata peel samples in an Akebia trifoliata genome sequence and an NCBI database, and selecting a 543bp fragment with high homology to design specific primers of the AtrANS genes, wherein the sequences of the primers are as follows:
f end primer: AAGGTTACCGAATTCTCTAGAACTAAAGGCTGTTGGTGAAGCTTT (SEQ ID NO: 7);
r terminal primer: TCCCCATGGAGGCCTTCTAGAATCTCTATGGTGTCCCCAATGTG (SEQ ID NO: 8);
the highly homologous atrabs gene fragment was ligated with linearized TRV2 vector to construct a vector, the vector construction procedure being as described previously in section 2.4.
2.6 analysis of transient overexpression of the pericarp of Akebia trifoliata
Configuration of transient expression aggressive liquor: the stored PBI121-GFP overexpressing Agrobacterium containing the AtrANS gene was activated in LB solid medium by streaking and cultured in the dark in a constant temperature incubator at 28 ℃. The monoclonal was then selected and inoculated into 1mL of liquid LB medium (containing kanamycin and rifampicin) and incubated overnight at 200r/min in a constant temperature shaker at 28℃until cloudy. Next, we transferred 100. Mu.L of the above broth to 50mL of liquid LB medium (containing kanamycin and rifampicin) and incubated overnight at 200r/min in a constant temperature shaker at 28 ℃. Finally, the bacterial solution was centrifuged at 5000rpm for 15 minutes, the medium was discarded and the pellet resuspended in MMA buffer (10 mM MgCl) 2 10mM MES, 200. Mu.M acetosyringone, pH=5.6) and OD 600 The value was adjusted to about 0.8 and 0.1% tween was added.
Infection of fresh akebia fruit peel: fruits with similar maturity and no mechanical damage and diseases and insect pests are selected as injection materials, fruits injected with a PBI121-GFP over-expression vector agrobacterium solution containing target gene fragments are used as experimental groups, the PBI121-GFP agrobacterium solution without target genes is injected and fruits without any treatment are used as negative controls, the resuspended bacteria solution is injected into pericarps by a compression method by using a 5mL sterile injector, the experiment is carried out in the S1 period, different parts of the fruits are injected, at least 2mL bacteria solution is injected into each part, and at least 20 fruits are injected into each group. After one week the fruits were retrieved from the tree, color phenotype digital photographs were taken, and the colored pericarp tissue was excised near the injection site, flash frozen in liquid nitrogen and stored in an ultra-low temperature refrigerator at-80 ℃.
2.7 analysis of Lespedeza trifoliata pericarp Virus mediated Gene silencing
Preparing a dip dyeing liquid: the method is the same as the 2.6 section, the constructed TRV2 silencing vector containing the AtrANS gene, the empty-load TRV2 silencing vector and the TRV1 agrobacterium solution are taken for activation and resuspended in MMA buffer, the TRV2 silencing vector containing the AtrANS gene and the empty-load TRV2 vector heavy suspension are respectively mixed with the TRV1 heavy suspension according to the volume ratio of 1:1, and 0.1 percent of Tween is added for preparing the intrusion solution.
Infection of fresh akebia fruit peel: and (3) standing the prepared dyeing solution at room temperature for 2 hours for use. With TRV2-AtrANS+TRV1 as experimental group and TRV2+TRV1 and non-injected as negative control, fresh Akebia trifoliata peel is infected in the S2 color transfer period, and the infection method is the same as that in section 2.6.
2.8 RT-qPCR determination of the expression level of the target Gene in the pericarp of Akebia trifoliata
Total RNA was extracted from pink pericarp (GP), purple pericarp (ZP), white pericarp (LW) using the SteadyPure Plant RNA Extraction Kit kit (Ai Kerui, changsha, china) according to the reference instructions. cDNA was synthesized using Evo M-MLV RT Premix for qPCR kit (Ai Kerui). The Primer is designed by Primer 5 and synthesized by the Optimago (Beijing). The primer sequence is 5'-AAGCGATTACATTGAGGT-3' (shown as SEQ ID NO: 9); 5'-GTAGAGGGCACTTAGGGT-3' (SEQ ID NO: 10). qRT-PCR reactions used 2X Sybr Green qPCR Mix mixtures (Aidlab, beijing, china), systems and procedures are shown in Table 7. 3 biological replicates were performed on a Bio-rad cfx96 Touch fluorescent quantitative PCR apparatus (Bio-rad, USA), each replicate performed 3 technical replicates for each reaction. A melting curve was generated at the end of each run for each sample. Raw data were analyzed using Excel 2016 and gene expression levels were determined using the 2- ΔΔCT method.
TABLE 7RT-qPCR reaction System and procedure
2.9 anthocyanin content in the pericarp of Akebia trifoliata
The specific extraction steps of anthocyanin in the colored pericarp of akebia trifoliate comprise: the sample is fully ground in liquid nitrogen, 1g of the sample is weighed, 10mL of 1% hydrochloric acid ethanol solution is added, shaking is carried out, dark is carried out for 12h at 4 ℃,5000g is centrifuged for 10min, the supernatant is taken, 10mL of 1% hydrochloric acid ethanol solution is used for extraction once, the supernatants of the two times are combined, the supernatant is transferred to a 25mL volumetric flask, the volume is fixed by 25mL, the supernatant is taken, the absorbance of the supernatant at 530nm, 620nm and 650nm is measured, and the measurement is repeated for 3 times for each sample.
ΔA=OD530-0.9*OD620-0.1*OD650,
TA=(ΔA/εL)*MW*DF*V/Wt*100,
Wherein TA is total anthocyanin content (mg/100 g), epsilon is molar absorbance (26900), L is optical path (1 cm) MW is standard molecular weight (449.2), DF is dilution factor, V is final volume (mL), MW is sample weight (g).
3. Results and analysis
3.1 analysis of the sequence of the AtrANS Gene in Akebia trifoliate
Anthocyanin synthase (ANS) is a 2-oxoglutarate (2 OG) and Fe (II) -dependent oxygenase that catalyzes the penultimate step in anthocyanin biosynthesis and converts colorless anthocyanin into colored anthocyanin, whose enzymatic activity affects anthocyanin synthesis. In order to understand the function of the AtrANS (Atr 08G 041820) in akebia trifoliate, the CDS fragment of the AtrANS is isolated from cDNA of ZP, and the nucleotide sequence of the CDS fragment is shown as SEQ ID NO: 1. The fragment consists of 1279bp open reading frame, contains 2 exons and 2 introns, is predicted to encode 426 residue polypeptide, and has a molecular formula of C 2171 H 3442 N 566 O 657 S 12 Molecular weight 48369.33 and bioinformatics analysis thereof are shown in Table 8. Analysis of the domains of the atlans protein using NCBI-CDD showed that the atlans protein contained a PLN03178 (anthocyanin synthase) multidomain protein comprising the morphine-synthesized N-terminal non-heme dioxygenase subfamily (diox_n) and 2-oxoglutarate-Fe 2+ -two conserved domains of the dioxygenase subfamily (2 OG-feii Oxy) (fig. 1), the amino acid sequence of the atrabs protein is shown in SEQ ID NO: 2.
TABLE 8 bioinformatics analysis of AtrANS
The atrabs gene nucleotides:
ATGGCAACACAAGTAGAGTAAAGTTACACCAAGGGTAGAGAGCTTAGCAAGCAATGGGATCCAAGCTATCCCTAAGGAGTACGACTGGAAAGAAGATCGCGAAAGCATCAACGATGTGTTCGAGGAGGAGAAGACATATAACGAAGCTCCACAGATACCCGTTATTGATTTAAATGGTGTCGATTCGGAGAAATGTAGGGAGGAGTCGAAGAAGGTTGATATTTCACCAAGGGTAGAGAGCTTGGCAAGTAGTGGGATCCAAGCTATTCCTAAGGAGTACATACGCTCGAAAGAAGAACGCGAAAGCATCAATGATGTGTTCGAGGAGGAAAAGAAGTATAACGAGGGTCCACAGATACCAACTATCGATTTAAAGGGTATCGAATCGGAGGAGGAGATGGTGAGGGAGAAATGTAGGGAGGAGTTGAAGGCGGCTTCAATGGAGTGGGGTGTAATGCATATAGTGAACCATGGTATACCTGATGATCTAATTCGTCGACTAAAGGCTGTTGGTGAAGCTTTCTTTGAACTCCCTATCGAGGAGAAGGAGAAGTATGCCAATGATCTGGCCTCGGGCAAAATCGCTGGGTATGGGAGCAAGCTTGCCAACAACGCCAACGGGCAACTCGAGTGGGAGGACTACTTCTTCCATCTCATATTTCCAGAAGAAAAGCGCGACATGTCAATTTGGCCTAAGATACCAAGCGATTACATTGAGGTGACGAGCGAGTATGCAAGGCAAATAAGAGTACTAGTGACCAAGATATTGTCAGTACTATCGCTTGGTTTGGGATTGGAAGAAGGAAGGCTAGAAACGGAAGTTGGTGGCATGGAGGAGTTATTATTGCAATTAAAGATTAACTACTACCCTAAGTGCCCTCTACCAGAATTAGCACTTGGGGTTGAAGCCCACACCGACATTAGCGCGCTCACCTTCATACTCCACAACATGGTTCCTGGCTTGCAAGTCCACTATAAAGACAAGTGGGTAACAGCAAAATGTGTCCCCGATTCAATCATCTTGCACATTGGGGACACCATAGAGATATTGAGCAATGGCAAGTACAAGAGTATACTTCATAGAGCACTAGTGAACAAGGAGAAGGTTAGGATATCGTGGCCCGTCTTCTGTGAGCCACCTAAAGAGAGCATTTTGCTCAGGCCTCTGTCTGAGCTTGTCACTGAGTCGGAGCCAGCACTCTTCCCACCTCGAACTTTTGCTCAACATATTCAACACAAGCTTTTCAAGAAAACCCAAGAAACTCTCCTCTCCAAATAA。
the atrabs protein amino acid:
MASSGIQAIPKEYIRSKEERESINDVFEEEKKYNEGPQIPTIDLKGIESEEEMVREKCREELKAASMEWGVMHIVNHGIPDDLIRRLKAVGEAFFELPIEEKEKYANDLASGKIAGYGSKLANNANGQLEWEDYFFHLIFPEEKRDMSIWPKIPSDYIEVTSEYARQIRVLVTKILSVLSLGLGLEEGRLETEVGGMEELLLQLKINYYPKCPLPELALGVEAHTDISALTFILHNMVPGLQVHYKDKWVTAKCVPDSIILHIGDTIEILSNGKYKSILHRALVNKEKVRISWPVFCEPPKESILLRPLSELVTESEPALFPPRTFAQHIQHKLFKKTQETLLSKMSIWPKIPSDYIEVTSEYARQIRVLVTKILSVLSLGLGLEEGRLETEVGGMEELLLQLKINYYPKCPLPELALGVEAHTDISALTFILHNMVPGLQVHYKDKWVTAKCVPDSIILHIGDT。
3.2 analysis of expression of the AtrANS Gene
The AtrANS gene is obtained from the transcriptome difference gene related to the anthocyanin synthesis of akebia trifoliate, and the expression analysis of the gene is carried out by utilizing pericarps with different phenotypes, so that the expression level of the gene in colored (purple and pink) materials is obviously higher than that of colorless (white) materials (see figure 2).
3.3 overexpression of AtrANS promotes the accumulation of Akebia trifoliata anthocyanin
In order to study the role of the AtrANS in the anthocyanin biosynthesis of akebia trifoliate, the invention carries out transient over-expression on the AtrANS gene in the pericarp of akebia trifoliate. PBI121-AtrANS-GFP and PBI121-GFP agrobacteria are injected into the pericarp of akebia trifoliata simultaneously, clear purple pigmentation appears after one week around the injection hole of PBI121-AtrANS-GFP compared with the empty PBI121-GFP, and fruits injected with PBI121-AtrANS-GFP and PBI121-GFP show obvious yellow color compared with CK which is not subjected to any treatment, and the fruits are possibly damaged by the injection of agrobacterium bacterial liquid and yellowing caused by stress. Compared with untreated peel, the expression level of the AtrANS in the treated peel and the anthocyanin content are obviously improved, the expression level of the AtrANS in the peel injected with the AtrANS-PBI121-GFP is 2.54 times that of the peel injected with the PBI121-GFP only and 9.15 times that of the peel not treated, the anthocyanin content also shows similar trend, and the anthocyanin content in the peel injected with the PBI121-AtrANS-GFP is highest (35.22 mg/100 g) and is obviously higher than that of the peel injected with the PBI121-GFP (15.04 mg/100 g) and the peel not treated (9.30 mg/100 g) (FIG. 3). These results indicate that the overexpression of the atrabs induces increased anthocyanin biosynthesis around the injection site, and that the atrabs positively regulates anthocyanin biosynthesis from the pericarp of akebia trifoliate.
3.4 inhibition of AtrANS by VIGS reduces anthocyanin accumulation in the pericarp of Akebia trifoliata
The function of the atrabs was further verified using the virus-induced gene silencing (VIGS) system. The agrobacteria heavy suspension of TRV2-AtrANS+TRV1 and TRV2+TRV1 is used as a material, and the agrobacteria heavy suspension is instantaneously permeated into the pericarp of akebia trifoliate in the S2 color conversion period. One week after the injection of TRV 2-atrabs+trv1, a decrease in purple pigmentation was observed at the injection site, whereas there was no more pronounced change in meat color at the site where trv2+trv1 was injected. The anthocyanin content of the pericarp around the injection site was measured and found to be significantly lower near the injection site of TRV2-AtrANS+TRV1 (46.00 mg/100 g) than the injection site of TRV2+TRV1 alone (60.97 mg/100 g) and the relative non-injection site (57.23 mg/100 g), which was closely related to the reduced expression level of AtrANS (FIG. 4). The results show that the AtrANS plays a positive regulation role in the biosynthesis of the anthocyanin of the pericarp of akebia trifoliate.
In general, the invention over-expresses the atlans gene in the pericarp of akebia trifoliate, promoting anthocyanin accumulation; silencing the AtrANS gene inhibits anthocyanin accumulation. These results demonstrate that the atlans gene can positively regulate the accumulation of anthocyanin, and promote the content of anthocyanin in the pericarp of akebia trifoliate; the method can also be used for over-expression by introducing an AtrANS gene into plants, so that the method is further applied to cultivation of new varieties of high anthocyanin plants.
Claims (10)
1. The akebia trifoliate anthocyanin synthesis regulatory gene AtrANS is characterized in that the nucleotide sequence is shown as SEQ ID NO: 1.
2. A primer pair for cloning the gene atrabs according to claim 1, characterized in that the base sequence is as follows:
an upstream primer: 5'-AATTGCACCAAGACGAAA-3';
a downstream primer: 5'-AATGTCATCAAGAGTGGTAC-3'.
3. An over-expression vector comprising vector PBI121-GFP, wherein said vector PBI121 comprises the gene atrabs of claim 1.
4. A primer pair for constructing the over-expression vector of claim 3, which has the following base sequence:
an upstream primer: 5'-GAGAACACGGGGGACTCTAGAATGGCAACACAAGTAGAGTAAAGTT ACA-3';
a downstream primer: 5'-GCTCACCATGGATCCTCTAGATTATTTGGAGAGGAGAGTTTCTTGG-3'.
5. A virus-induced gene silencing vector comprising vector TRV2, wherein the vector TRV2 comprises the gene AtrANS according to claim 1.
6. A primer pair for constructing the gene silencing vector of claim 5, wherein the base sequence is as follows:
an upstream primer: 5'-AAGGTTACCGAATTCTCTAGAACTAAAGGCTGTTGGTGAAGCTTT-3';
a downstream primer: 5'-TCCCCATGGAGGCCTTCTAGAATCTCTATGGTGTCCCCAATGTG-3'.
7. The protein encoded by the gene atlans according to claim 1, wherein the amino acid sequence is set forth in SEQ ID NO: 2.
8. Use of the gene atrabs according to claim 1 for increasing anthocyanin content in akebia trifoliate pericarp.
9. Use of the gene atrabs according to claim 1 for breeding new varieties of high anthocyanin plants.
10. The use according to claim 9, wherein the plant is akebia trifoliata.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310765301.2A CN116790637A (en) | 2023-06-27 | 2023-06-27 | Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310765301.2A CN116790637A (en) | 2023-06-27 | 2023-06-27 | Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116790637A true CN116790637A (en) | 2023-09-22 |
Family
ID=88049319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310765301.2A Pending CN116790637A (en) | 2023-06-27 | 2023-06-27 | Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116790637A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117660489A (en) * | 2023-12-15 | 2024-03-08 | 河南农业大学 | Peanut seed coat color regulation related gene AhPSC1 and related application thereof |
-
2023
- 2023-06-27 CN CN202310765301.2A patent/CN116790637A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117660489A (en) * | 2023-12-15 | 2024-03-08 | 河南农业大学 | Peanut seed coat color regulation related gene AhPSC1 and related application thereof |
CN117660489B (en) * | 2023-12-15 | 2024-05-03 | 河南农业大学 | Peanut seed coat color regulation related gene AhPSC1 and related application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Niu et al. | Coordinated regulation of anthocyanin biosynthesis in Chinese bayberry (Myrica rubra) fruit by a R2R3 MYB transcription factor | |
Gao et al. | Characterization of the ABA receptor VlPYL1 that regulates anthocyanin accumulation in grape berry skin | |
CN108588092B (en) | Pear anthocyanin synthetic transcription factor PbMYB109 and application thereof | |
CN110066326B (en) | Salt mustard transcription factor EsMYB41 for regulating plant anthocyanin synthesis, and coding gene and application thereof | |
Zhu et al. | Ectopic expression of the coleus R2R3 MYB-type proanthocyanidin regulator gene SsMYB3 alters the flower color in transgenic tobacco | |
CN114014917B (en) | FvbHLH36 protein, and encoding gene and application thereof | |
CN107164391A (en) | A kind of strawberry floral genes FvbHLH78 and its application | |
CN116790637A (en) | Akebia trifoliata anthocyanin synthesis regulatory gene AtrANS and encoding protein and application thereof | |
CN107056911A (en) | A kind of strawberry transcription factor for promoting plant Blooming and its application | |
CN107299103B (en) | Thick boisiana IpASR gene and its coding albumen and application | |
CN108840915A (en) | Moso bamboo PeDi19-4 albumen and its encoding gene and application | |
CN106591320A (en) | Betula platyphylla BplSPL1 gene for promoting precocious flowering and encoded protein thereof | |
CN110452917B (en) | Wild grape VyGOLS gene and application of encoding protein thereof in drought stress | |
CN106967161A (en) | Regulate and control the albumen of anthocyanidin content and its encoding gene and application in Blueberry | |
CN115197951B (en) | Tea tree flavonol synthesis candidate gene CsNAC086 and application thereof | |
CN113881685B (en) | Gene PpHSP20-like1 for promoting plant organ to produce red color and application thereof | |
CN108004267B (en) | Method for prolonging shelf life of tomato fruits by using genetic engineering technology | |
CN113999828B (en) | Application of strawberry methyltransferase MTA and MTB genes in control of strawberry maturation | |
CN114410647B (en) | Gene PeNHX1 for regulating and controlling petal color of butterfly orchid and application thereof | |
CN115851813A (en) | Application of camellia oleifera CoBBX22 protein in regulation and control of plant drought tolerance | |
CN112029778B (en) | Potato anthocyanin synthesis regulation gene StWRKY13 and application thereof | |
CN114230651A (en) | Method for instantaneously changing color of dendrobium nobile by using DhMYB2 gene | |
CN113322262A (en) | Gene HuDOPA for controlling synthesis of pitaya beet pigment | |
CN111019911A (en) | Protein of 8' -hydroxylase CYP707A protein critical to abscisic acid degradation pathway, coding gene and application thereof | |
CN113512553B (en) | Potato TF72354 gene and application thereof in anthocyanin synthesis regulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |